INTRA-CELLULAR THERAPIES, INCINTRA-CELLULAR THERAPIES, INCINTRA-CELLULAR THERAPIES, INC

INTRA-CELLULAR THERAPIES, INC

No trades
See on Supercharts

Price target

1674.900.00 0.00%
The 16 analysts offering 1 year price forecasts for ITCI have a max estimate of — and a min estimate of —.

Analyst rating

Based on 17 analysts giving stock ratings to ITCI in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ITCI EPS for the last quarter is −2.65 MXN despite the estimation of −5.26 MXN. In the next quarter EPS is expected to reach −3.49 MXN. Track more of INTRA-CELLULAR THERAPIES, INC financials and stay on top of what is up with the company.
In the next quarter INTRA-CELLULAR THERAPIES, INC revenue is expected to reach ‪2.92 B‬ MXN. Check out INTRA-CELLULAR THERAPIES, INC revenue and earnings and make informed decisions.
According to analysts, ITCI price target is 1674.90 MXN with a max estimate of 2175.49 MXN and a min estimate of 1178.39 MXN. Check if this forecast comes true in a year, meanwhile watch INTRA-CELLULAR THERAPIES, INC stock price chart and keep track of the current situation with ITCI news and stock market news.
We've gathered opinions of 17 analysts rating ITCI stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.